Endoscopic vacuum therapy (EVT) for early infradiaphragmal leakage after bariatric surgery—outcomes of six consecutive cases in a single institution
- 23 Downloads
Anastomotic leakages or staple line defects after Roux-en-Y gastric bypass (RYGB) and primary laparoscopic sleeve gastrectomy (LSG), respectively, with consecutive bariatric revisional surgery are associated with relevant morbidity and mortality rates. Endoscopic vacuum therapy (EVT) with or without stent-over-sponge (SOS) has been shown to be a promising therapy in foregut wall defects of various etiologies and may therefore be applied in the treatment of postbariatric leaks.
We report the results of six consecutive patients treated with EVT (83% in combination with SOS) for early postoperative leakages in close proximity to the esophagogastric junction (EGJ) after LSG (n = 2) and RYGB (n = 4) from May 2016 to May2018.
All patients (2/6 male, median age 51 years, median BMI 44.2 kg/m2) were treated successfully without further signs of persisting leakage at the last gastroscopy. The lesions’ size ranged from 0.5 cm2 to 9 cm2, and the leaks were connected to large (max. 225 cm2) abscess cavities in 80% of the cases. Median duration of treatment (= EVT in situ) was 23.5 days (range, 7–89). The number of endoscopic interventions ranged from 1 to 24 (median, n = 7), with a median duration between vacuum sponge replacements of 4 days.
EVT is an effective and safe treatment for staple line defects or anastomotic leakage after bariatric surgeries and can therefore be adopted for the treatment of midgut wall defects. Further studies with a greater number of patients comparing surgical drainage alone or in combination with EVT versus EVT alone are needed.
KeywordsEndoscopic vacuum therapy Stent-over-sponge Laparoscopic sleeve gastrectomy Roux-en-Y gastric bypass Anastomotic leakage SEMS
Laparoscopic sleeve gastrectomy
Roux-en-Y gastric bypass
Self-expandable metal stent
Endoscopic vacuum therapy
Study concept and design: Bernhard Morell, Fritz Murray, Christoph Gubler. Acquisition of data: Bernhard Morell, Fritz Murray, Marco Bueter. Analysis and interpretation of data: Bernhard Morell, Fritz Murray, Christoph Gubler. Drafting of manuscript: Bernhard Morell, Fritz Murray. Critical revision of manuscript: Marco Bueter, Diana Vetter.
Compliance with ethical standards
We (the authors) have nothing to disclose. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
- 1.WHO (2017) Obesity and overweight, World Health Organisation Factsheet. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed 15.08.2018
- 10.Weidenhagen R, Gruetzner KU, Wiecken T, Spelsberg F, Jauch KW (2008) Endoluminal vacuum therapy for the treatment of anastomotic leakage after anterior rectal resection. Rozhl Chir 87(8):397–402Google Scholar
- 15.Schniewind B, Schafmayer C, Voehrs G, Egberts J, von Schoenfels W, Rose T, Kurdow R, Arlt A, Ellrichmann M, Jurgensen C, Schreiber S, Becker T, Hampe J (2013) Endoscopic endoluminal vacuum therapy is superior to other regimens in managing anastomotic leakage after esophagectomy: a comparative retrospective study. Surg Endosc 27(10):3883–3890CrossRefGoogle Scholar
- 18.Seyfried F, Reimer S, Miras AD, Kenn W, Germer CT, Scheurlen M, Jurowich C (2013) Successful treatment of a gastric leak after bariatric surgery using endoluminal vacuum therapy. Endoscopy 45(Suppl 2 UCTN):E267–E268Google Scholar